CClinicalTrials.gg
CompletedNCT06218836Updated Apr 27, 2026

Effect of Inflated Versus Non-inflated Endotracheal Tube on Sore Throat

An interventional study of Pre-inflated endotracheal tube and Non-inflated endotracheal tube in Postoperative Sore Throat, sponsored by Sir Ganga Ram Hospital. Completed at 1 site in India. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-27.

Sponsored by Sir Ganga Ram Hospital · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Postoperative sore throat (POST) is a common morbidity following upper airway access-control with direct laryngoscopy-intubation (DLI) technique. Various reasons (size of the tracheal tube, cuff pressure, rough tube pass, and reattempts, among others) have been cited and management strategies (pharmacologic: applying lidocaine gel/EMLA cream on the cuff surface; non-pharmacologic measures: tracheal tube cuff pressure control, optimization of tracheal tube size, applying lubricating gel) have been tried, but none has been able to decrease the incidence of POST nor has been able to decrease the suffering of patients.

Traditionally, intubation is performed with a deflated endotracheal tube and the cuff is later inflated to secure the tube in desired position. The striated folds present in the deflated cuff incurs additional dynamic friction that traumatizes upper airway mucosa during the procedure, causing the risk of POST. While accentuated friction burden on the posterior part of vocal cords and the tracheal mucosa has been studied recently, there has been no work on understanding the kinetic contact- friction ensued by a passing tracheal tube/cuff. We speculate that dynamic contact-friction generated at the time of passing of a cuffed tracheal tube is the major active component which has potential to cause actual tissue trauma and inflammation resulting in adverse effects (POST, hoarseness, throat pain, cough). This study aims to evaluate the effects of reducing dynamic/kinetic contact-friction by employing a pre-inflated tracheal tube cuff to pass the vocal cords at the time of orotracheal intubation.

Read the detailed description

Postoperative sore throat (POST) has long been a common and nagging complication following conventional direct laryngoscopy-intubation (DLI) procedure. A significant quantum of POST incidence during DLI in non-difficult airway (NDA) could be attributed to inter-operator variability in approach, experience, proficiency, and equipment (e.g., type of laryngoscope/tracheal tube). Additional factors determining the occurrence of POST, include size of the tracheal tube, cuff pressure, rough tube pass, and reattempts, among others. Several pharmacologic (applying lidocaine gel, inhaled corticosteroids and EMLA cream on tracheal tube cuff surface) and non- pharmacologic measures/modalities (e.g., tracheal tube cuff pressure control, optimization of tracheal tube size, applying gel) have been employed to preclude/diminish POST, however, neither the incidence nor the suffering of patients have come down yet following these interventions. Friction injury to the tracheal mucosa during the passage of ETT is one of the important contributing factors to POST but has not been adequately evaluated. Friction injury to the upper airway mucosa not only occurs during rough or repeated passage of ETT through the glottic-inlet but also when the ETT cuff comes in contact with the tracheal mucosa during dynamic passage of ETT through the glottis.

Traditional approach to reduce reduce postoperative sore throat is by containing the intracuff pressure with use of non-inflated tube, and consequently, reducing static pressure burden on tracheal mucosa. No study has explored the impact of modulation of obligate kinetic contact-friction that occurs during passage of tube across the glottic-inlet. A preemptive limited inflation of tracheal tube cuff before actual intubation may modulate the kinetic-contact friction during the passage of the tracheal tube cuff past the vocal cords, and hence may help reduce postoperative sore throat in these patients. We plan this randomized trial to compare the effect/efficacy of intubation with pre-inflated tracheal tube on the incidence of postoperative sore throat in patients with anticipated non-difficult airway.

02

Conditions studied

  • Postoperative Sore Throat

Browse trials for

Keywords

  • endotracheal tube
  • inflated
  • sore throat
  • friction
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ASA physical status I and II
  • Patients with anticipated non-difficult airway with the following characteristics:

    i. Normal head and neck movements ii. Adequate mouth opening iii. No retrognathia or prognathia iv. Normal dentition

  • Surgeries with anticipated duration of 40 minutes - 3 hours

Exclusion criteria

Exclusion Criteria:

  • Obese patients (BMI > 33 kg/m2)
  • Requiring use of intubation aids such as bougie, stylet or video-laryngoscope
  • Recent history of steroid or non-steroidal anti-inflammatory drug use
  • Systemic illness with presenting complaints of sore/dry throat (diabetics with polydipsia, hypertensives on diuretics, moribund bed ridden patients)
  • History of airway related morbidity post operative sore throat [POST]
  • Patients with a history of chronic smoking (1 pack per day for 10 years) chewing tobacco, and tobacco-related products
  • Patients undergoing head and neck, intraoral/nasal surgery, or recent history of such surgery
  • Patients with a past surgical history of tracheostomy (post decannulation)
  • Surgery in prone position
  • Ongoing upper and lower respiratory tract inflammation/infection
  • Patients with anticipated postoperative mechanical ventilation
  • Refusal to participate in the study
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
250 participants (actual)

Study arms

  • Active comparator
    Intubation with pre-inflated ETT

    Patient's trachea will be intubated using pre- inflated endotracheal tube (ETT)

    Other: Pre-inflated endotracheal tube

  • Active comparator
    Intubation with non-inflated ETT

    Patient's trachea will be intubated using non-inflated ETT

    Other: Non-inflated endotracheal tube

Interventions

  • OtherPre-inflated endotracheal tube

    The ETT (males: size 7.5 mm ID, females: size 6.5 mmID) will be taken out from the wrapper and submerged in 0.9% normal saline till the proximal margin of the cuff. Then, the cuff will be inflated to 40 cm of H2O to gain full stretch inflation.Thereafter the cuff will be deflated with the help of cuff inflator-deflator device to maintain intracuff pressure of 4 cm H2O The external cuff balloon will be obliterated with a soft clamp to ensure that at the time of passage of tube through the glottic-inlet, the tube cuff does not get deflated due to pressure equalization with the external balloon.

  • OtherNon-inflated endotracheal tube

    The ETT (males: size 7.5 mm ID, females: size 6.5 mmID) will be taken out from the wrapper and submerged in 0.9% normal saline till the proximal margin of the cuff. Thereafter the endotracheal intubation will be done.

05

What researchers measure

Primary outcomes

  1. Incidence of postoperative sore throat

    Sore throat will be assessed using a 4-point scale: '0' no sore throat to '3' severe sore throat.Any score \>= 1 will be counted as a sore throat incidence

    Time frame: From time of extubation of trachea till 24-hours postoperatively

Secondary outcomes

  1. Severity of postoperative sore throat

    Sore throat will be assessed using a 4-point scale: '0' no sore throat, '1' Mild sore throat (complained of sore throat only on enquiry), '2' Moderate sore throat (complained of sore throat on his/her own), and '3' Severe sore throat (change of voice or hoarseness). Number of patients with no sore throat, mild sore throat, moderate sore throat, and severe sore throat will be noted

    Time frame: From time of extubation of trachea till 24-hours postoperatively

  2. Incidence and severity of postoperative cough

    Postoperative cough will be assessed using a 4-point scale: 0- no cough, 1- mild cough (cough which is less than a common cold), 2-moderate cough (cough which is similar to a common cold), and 3- severe cough (cough which is more than a common cold).

    Time frame: From time of extubation of trachea till 24-hours postoperatively

  3. Incidence and severity of postoperative hoarseness of voice

    Postoperative hoarseness of voice will be assessed using a 4-point scale: 0- no hoarseness (no change in speech appreciated even on enquiry), 1- mild hoarseness (minimal change in speech quality. Answered by patient on enquiry), 2-moderate hoarseness (moderate change in speech quality which is self-complained by the patient), and 3- severe hoarseness (recognizable change in speech quality).

    Time frame: From time of extubation of trachea till 24-hours postoperatively

06

Study locations

1 site
  • Sir Ganga Ram Hospital
    New Delhi, National Capital Territory of Delhi 110060, India
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06218836
Lead sponsor
Sir Ganga Ram Hospital
Responsible party
Nitin Sethi, DNB (Senior Consultant, Sir Ganga Ram Hospital) — Principal investigator
First posted
Jan 23, 2024
Start date
Jan 23, 2024
Primary completion
Jul 21, 2025
Completion
Jul 21, 2025
Last update
Apr 27, 2026

Study contacts

Amitabh Dutta, MD, PGDHR
study director · Sir Ganga Ram Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion